Learning through a pandemic: the current state of knowledge on COVID-19 and cancer

A Elkrief, JT Wu, C Jani, KT Enriquez, M Glover… - Cancer discovery, 2022 - AACR
The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

[HTML][HTML] COVID-19 in the homeless population: a scoping review and meta-analysis examining differences in prevalence, presentation, vaccine hesitancy and …

T Ahillan, M Emmerson, B Swift, H Golamgouse… - BMC infectious …, 2023 - Springer
Aims People experiencing homelessness (PEH) have been identified as being increasingly
susceptible to Coronavirus disease (COVID-19), with policies enacted to test, isolate …

Association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer

IY Gong, A Vijenthira, M Powis, A Calzavara… - JAMA …, 2023 - jamanetwork.com
Importance Patients with cancer are known to have increased risk of COVID-19
complications, including death. Objective To determine the association of COVID-19 …

[HTML][HTML] COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway

TB Johannesen, S Smeland, S Aaserud… - Frontiers in …, 2021 - frontiersin.org
Background Cancer has been suggested as a risk factor for severe outcome of SARS-CoV-2
infection. In this population-based study we aimed to identify factors associated with higher …

[HTML][HTML] COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2

L Zhang, C Wei, D Li, J He, S Liu, H Deng… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
CTSL is expressed by cancerous tissues and encodes a lysosomal cysteine proteinase that
regulates cancer progression and SARS-CoV-2 entry. Therefore, it is critical to predict the …

[HTML][HTML] Early administration of convalescent plasma improves survival in patients with hematological malignancies and COVID-19

MM Biernat, A Kolasińska, J Kwiatkowski… - Viruses, 2021 - mdpi.com
The use of convalescent plasma in the treatment of COVID-19 may lead to a milder course of
infection and has been associated with improved outcomes. Determining optimal treatments …

[HTML][HTML] COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2

D Li, X Liu, L Zhang, J He, X Chen, S Liu… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Furin is a proprotein convertase that activates different kinds of regulatory proteins, including
SARS-CoV-2 spike protein which contains an additional furin-specific cleavage site. It is …

Oncologist perspectives on telemedicine for patients with cancer: a national comprehensive cancer network survey

AJ Tevaarwerk, T Chandereng, T Osterman… - JCO oncology …, 2021 - ascopubs.org
PURPOSE: The use of telemedicine expanded dramatically in March 2020 following the
COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine's …

[HTML][HTML] COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)

L Castelo-Branco, Z Tsourti, S Gennatas, J Rogado… - ESMO open, 2022 - Elsevier
Background ESMO COVID-19 and CAncer REgistry (ESMO-CoCARE) is an international
collaborative registry-based, cohort study gathering real-world data from Europe …

[HTML][HTML] COVID-19 vaccination acceptance and its associated factors among cancer patients in Tunisia

H Khiari, I Cherif, F M'ghirbi, A Mezlini… - Asian Pacific Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Vaccination is the most effective way to fight the COVID-19 pandemic and to
protect people who have a higher risk of developing severe illness and death from COVID …